Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Osiris Therapeutics Inc

+ Add to Watchlist


16.8800 USD 0.0200 0.12%

As of 20:10:00 ET on 01/27/2015.

Snapshot for Osiris Therapeutics Inc (OSIR)

Open: 17.0300 Day's Range: 16.6100 - 17.0500 Volume: 53,156
Previous Close: 16.9000 52wk Range: 11.8004 - 17.6000 1-Yr Rtn: +2.06%

Stock Chart for OSIR

No chart data available.
  • OSIR:US 16.8900
  • 1D
  • 1M
  • 1Y
Interactive OSIR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OSIR

Current P/E Ratio (ttm) 287.7551
Estimated P/E(12/2014) -
Relative P/E vs. SPX 16.1165
Earnings Per Share (USD) (ttm) 0.0587
Est. EPS (USD) (12/2014) -0.0170
Est. PEG Ratio -
Market Cap (M USD) 579.32
Shares Outstanding (M) 34.32
30 Day Average Volume 140,147
Price/Book (mrq) 7.0550
Price/Sale (ttm) 11.8721
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OSIR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OSIR

Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects.

Lode DebrabanderePresident/CEOPhilip R Jacoby JrCFO/Treasurer/Secretary
Jonathan M Hopper "Jon"Chief Medical OfficerFrank D Czworka JrVP/General Manager:Wound Care
More Company Profile & Key Executives for OSIR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil